NCT01918683View on ClinicalTrials.gov

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

TACE transarterial chemoembolization

RADIATION

stereotatic body radiotherapy (SBRT)

Trial Locations (3)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

60153

Loyola University Medical Center, Maywood

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Loyola University

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01918683 - TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients | Biotech Hunter | Biotech Hunter